[1] Stan C,Diaconu E,Hopirca L,et al.Ocular Cicatricial
Pemphigoid[J].Rom J Ophthalmol,2020,64(2):226-230.
[2] You C,Lamba N,Lasave AF,et al.Rituximab in the
treatment of ocular cicatricial pemphigoid: a retrospective
cohort study[J].Graefes Arch Clin Exp Ophthalm
ol,2017,255(6):1221-1228.
[3] Georgoudis P,Sabatino F,Szentmary N,et al.Ocular
Mucous Membrne Pemphigoid:Current State of
Pathophysiology,Diag-nostics and Treatment[J].
Ophthalmology and Therapy,2019,8(1):5-17.
[4] Ong HS,Setterfield JF,Minassian DC,et al.Mucous
Membrane Pemphigoid with Ocular Involvement:
The Clinical Phenotype and Its Relationship to Direct
I m m u n o f l u o r e s c e n c e F i n d i n g s [ J ] . O p h t h a l m o l o
gy,2018,125(4):496-504.
[5] Wang K,Seizman G,Gonzades JA.Ocular Cicatricial
Pemphigoid[J].Cerr Opin Qphthalmol,2018,29(6):543-551.
[6] Kate A,Shanbhag S,Donthineni PR,et al.A case series of
ocular involvement in bullous pemphigoid: clinical features,
management, and outcomes[J].F1000Res,2021,10:1201.
[8] Buonavoglia A,Leone P,Dammacco R,et al.Pemphigus and
mucous membrane pemphigoid:An up date from diagnosis
to therapy[J].Autoimmun Rev,2019,18(4):349-358.
